Cargando…

Electrochemical Immunosensor Based on Polythionine/Gold Nanoparticles for the Determination of Aflatoxin B(1)

An aflatoxin B(1) (AFB(1)) electrochemical immunosensor was developed by the immobilisation of aflatoxin B(1)-bovine serum albumin (AFB(1)-BSA) conjugate on a polythionine (PTH)/gold nanoparticles (AuNP)-modified glassy carbon electrode (GCE). The surface of the AFB(1)-BSA conjugate was covered with...

Descripción completa

Detalles Bibliográficos
Autores principales: Owino, Joseph H.O., Arotiba, Omotayo A., Hendricks, Nicolette, Songa, Everlyne A., Jahed, Nazeem, Waryo, Tesfaye T., Ngece, Rachel F., Baker, Priscilla G.L., Iwuoha, Emmanuel I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791018/
https://www.ncbi.nlm.nih.gov/pubmed/27873987
http://dx.doi.org/10.3390/s8128262
Descripción
Sumario:An aflatoxin B(1) (AFB(1)) electrochemical immunosensor was developed by the immobilisation of aflatoxin B(1)-bovine serum albumin (AFB(1)-BSA) conjugate on a polythionine (PTH)/gold nanoparticles (AuNP)-modified glassy carbon electrode (GCE). The surface of the AFB(1)-BSA conjugate was covered with horseradish peroxidase (HRP), in order to prevent non-specific binding of the immunosensors with ions in the test solution. The AFB(1) immunosensor exhibited a quasi-reversible electrochemistry as indicated by a cyclic voltammetric (CV) peak separation (ΔE(p)) value of 62 mV. The experimental procedure for the detection of AFB(1) involved the setting up of a competition between free AFB(1) and the immobilised AFB(1)-BSA conjugate for the binding sites of free anti-aflatoxin B(1) (anti-AFB(1)) antibody. The immunosensor's differential pulse voltammetry (DPV) responses (peak currents) decreased as the concentration of free AFB(1) increased within a dynamic linear range (DLR) of 0.6 - 2.4 ng/mL AFB(1) and a limit of detection (LOD) of 0.07 ng/mL AFB(1). This immunosensing procedure eliminates the need for enzyme-labeled secondary antibodies normally used in conventional ELISA–based immunosensors.